Join
Live feed
·
PRReleasevia Quantisnow
Abivax SA logo

Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis

ByQuantisnow·Wall Street's wire, on your screen.
ABVX· Abivax SA
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABVX (Abivax SA) and more on Quantisnow.